-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2021 to Q3 2025.
- Calidi Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$5.05M, a 3.41% increase year-over-year.
- Calidi Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$19.8M, a 28.2% increase year-over-year.
- Calidi Biotherapeutics, Inc. annual Operating Income (Loss) for 2024 was -$21.8M, a 24.9% increase from 2023.
- Calidi Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$29M, a 25.4% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)